New AI-powered tool uses test results to predict which Barrett's esophagus patients have a high or low risk of developing cancer in the next 5 years.
Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced a strategic Research and Development Agreement with Amsterdam UMC and Eindhoven University of Technology to develop and ...
Plano gastroenterologist explains GERD complications, Barrett’s esophagus risk factors and when to seek screening.
The study, published in Nature Communications, used family studies and genetically engineered mice to understand how gene defects contribute to disease.
The firefighters union in Kentwood held an event Thursday providing precancer screenings using a DNA test. The U.S. Fire ...
(DecisionDx®-Melanoma, TissueCypher®) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million ...
Recent studies show that coffee consumption’s role in gastrointestinal disorders, from GERD to cancer, is nuanced, underscoring the need for individual assessment.
NERD, or non-erosive reflux disease, is a form of GERD in which people experience chronic acid reflux symptoms but have a ...
So, how do you accommodate having a hiatal hernia? Here are some tips: ...
Castle Biosciences, Inc. ( CSTL) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST Good afternoon, and welcome to Castle Biosciences Fourth Quarter and Full Year 2025 Conference Call. As a reminder, ...
(DecisionDx-Melanoma, TissueCypher) increased 37% over 2024 Exceeded 2025 guidance with full-year revenue of $344 million Conference call and webcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results